Rogier Christian Buijsman

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Netherlands Translational Research Center B.v., Merck Sharp + Dohme Corp., Sanofi-Aventis. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rogier Christian Buijsman. Retrieved from https://idiyas.com/inventor/rogier-christian-buijsman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 10(Granted Patents)

Location History:

MK Berghem, NL (2019)
Berghem, NL (2020)
Oss, NL (2002 - 2024)

Company Filing History:

6 out of 8

Netherlands Translational Research Center B.v.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

4. 1 out of 834,570

Other

patents

Years Active: 2002-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50082 - (5,6-dihydro)pyrimido[4,5-e]indolizines (2024-08-20),

2. RE48974 - (5,6-dihydro)pyrimido[4,5-E]indolizines (2022-03-14),

3. 11053230 - 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase (2021-07-06),

4. 10689343 - Inhibitors of tryptophan 2,3-dioxygenase (2020-06-23),

5. 10494360 - Inhibitors of indoleamine 2,3-dioxygenase (2019-12-03),

6. 9856258 - (5,6-dihydro)pyrimido[4,5-E]indolizines (2018-01-02),

7. 8133885 - Non steroidal glucocorticoid receptor modulators (2012-03-13),

8. 7576071 - Antithrombotic compound (2009-08-18),

9. 6486129 - Antithrombotic compounds (2002-11-26),

Title: The Innovative Contributions of Rogier Christian Buijsman

Introduction

Rogier Christian Buijsman is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can be utilized in cancer treatment. With a total of nine patents to his name, Buijsman has established himself as a key figure in innovation.

Latest Patents

Among his latest patents are the compounds known as (5,6-dihydro)pyrimido[4,5-e]indolizines. These compounds are characterized by a specific formula where R and R are independently selected from a group consisting of optionally substituted (6-10C) aryl and (1-5C) heteroaryl groups. The potential applications of these compounds lie in pharmaceutical compositions, particularly for the treatment of cancer.

Career Highlights

Buijsman has worked with the Netherlands Translational Research Center B.V., where he has contributed to various research initiatives. His work has focused on the intersection of chemistry and medicine, leading to advancements in therapeutic options for cancer patients.

Collaborations

Throughout his career, Buijsman has collaborated with notable individuals such as Adrianus Petrus Antonius De Man and Guido Jenny Rudolf Zaman. These collaborations have further enriched his research and development efforts.

Conclusion

Rogier Christian Buijsman is a distinguished inventor whose work in pharmaceutical innovation has the potential to impact cancer treatment significantly. His contributions through patents and collaborations highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.